These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22704119)

  • 1. Is adjunctive systemic chemotherapy after cystectomy for T2N+ disease of therapeutic benefit?
    Galsky MD; Tagawa ST; Shariat SF
    J Urol; 2012 Aug; 188(2):358-60. PubMed ID: 22704119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is down-staging of advanced bladder cancer by neoadjuvant chemotherapy possible?--MVEC protocol].
    Hoch V; Noll F; Schreiter F
    Urologe A; 1992 Jul; 31(4):243-6. PubMed ID: 1514212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
    Stöckle M
    Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
    Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
    Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
    Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O
    Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant chemotherapy after cystectomy for bladder tumors staged as superior or equal to pT3].
    Schmid HP; Studer UE
    Prog Urol; 1997 Feb; 7(1):102-4. PubMed ID: 9116724
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer.
    Chechile G; Montie J; Pontes JE; Bukowski RM
    Prog Clin Biol Res; 1990; 353():153-61. PubMed ID: 2217413
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
    Walther PJ
    Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K; Chihara Y; Kondo H; Hirao Y
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.
    Sternberg CN; Parmar MK
    J Clin Oncol; 2001 Sep; 19(18 Suppl):21S-26S. PubMed ID: 11560967
    [No Abstract]   [Full Text] [Related]  

  • 13. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
    Bajorin DF
    J Clin Oncol; 2001 Sep; 19(18 Suppl):17S-20S. PubMed ID: 11560966
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?
    Hall RR
    Acta Urol Belg; 1996 May; 64(2):39-42. PubMed ID: 8701809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer?].
    Suttmann H; Retz M; Gschwend JE; Stöckle M
    Urologe A; 2007 Oct; 46(10):1379-80, 1382-4. PubMed ID: 17805506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of neoadjuvant chemotherapy for invasive bladder cancer.
    Martínez-Piñeiro JA; Martínez-Piñeiro L
    Br J Urol; 1998 Jul; 82(1):33-42. PubMed ID: 9698660
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy for bladder cancer.
    Sternberg CN; Calabró F
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):987-92. PubMed ID: 16336089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inductive chemotherapy of bladder cancer. A critical evaluation].
    Debruyne FM
    Urologe A; 1991 Mar; 30(2):81-4. PubMed ID: 2058072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.